Cited by 33Neuropeptides and Animal PhysiologyMemory and Neural MechanismsNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record.

Stimulation of δ1- and δ2-opioid receptors produces amnesia in mice

Ukai, Makoto, Takada, Akio, Sasaki, Yusuke, Kameyama, Tsutomu·1997·European Journal of Pharmacology

Abstract

The effects of intracerebroventricular administration of delta1- and delta2-selective opioid receptor agonists on spontaneous alternation performance, elevated plus-maze behavior and passive avoidance learning including step-down and step-through types were examined in mice. Although the delta1-selective opioid receptor agonist, [D-Pen2,L-Pen5]enkephalin (DPLPE) (1-10 microg) or the delta2-selective opioid receptor agonist, [D-Ala2]deltorphin II (deltorphin) (1-10 microg) did not markedly affect spontaneous alternation performance or elevated plus-maze behavior, DPLPE (1, 3 and/or 10 microg) and deltorphin (3 and 10 microg) inhibited passive avoidance learning including step-down and step-through types. The delta1-selective opioid receptor antagonist, 7-benzylidenenaltrexone (3.5 ng), and the delta2-selective opioid receptor antagonist, naltriben (19 ng), significantly antagonized the inhibitory effects of DPLPE (3 microg) and deltorphin (3 microg) on passive avoidance learning, respectively. In contrast, DPLPE (3 microg) or deltorphin (3 microg) did not markedly influence behavioral responses induced by electroshocks during training of passive avoidance learning. Moreover, DPLPE (0.3-3 microg) or deltorphin (0.3-3 microg) failed to significantly affect the radiant heat-induced nociceptive responses. These results suggest that stimulation of delta1- and delta2-opioid receptors produces amnesia, depending on the learning tasks used.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0014-2999(97)01310-1

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 37

  1. Beninger, 1986, Effects of scopolamine and unilateral lesions of the basal forebrain on T-maze spatial discrimination and alternation in rats, Pharmacol. Biochem. Behav., 24, 1353, 10.1016/0091-3057(86)90195-4 · DOI
  2. Bhargava, 1996, Effects of chronic administration of 7-benzylidene-7-dehydronaltrexone and naltriben on the antinociceptive actions of δ1- and δ2-opioid receptor agonists, Eur. J. Pharmacol., 311, 127, 10.1016/0014-2999(96)00411-6 · DOI
  3. De Wied, 1978, Behavioral and electrophysiological effects of peptides related to lipotropin (β-LPH), J. Pharmacol. Exp. Ther., 204, 570, 10.1016/S0022-3565(25)31174-2 · DOI
  4. Dhawan, 1996, International union of pharmacology. XII. Classification of opioid receptors, Pharmacol. Rev., 48, 567, 10.1016/S0031-6997(25)06958-3 · DOI
  5. Erspamer, 1989, Deltorphins: A family of naturally occurring peptides with high affinity and selectivity for δ opioid binding sites, Proc. Natl. Acad. Sci. USA, 86, 5188, 10.1073/pnas.86.13.5188 · DOI
  6. Fang, 1994, Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: Evidence for delta opioid receptor heterogeneity, J. Pharmacol. Exp. Ther., 268, 836, 10.1016/S0022-3565(25)39017-8 · DOI
  7. Fowler, 1994, μ-, δ-, κ-Opioid receptors and their subtypes: A critical review with emphasis on radioligand binding experiments, Neurochem. Int., 24, 401, 10.1016/0197-0186(94)90089-2 · DOI
  8. Haley, 1957, Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse, Br. J. Pharmacol., 12, 12
  9. Hammond, 1995, Antinociception and δ-1 opioid receptors in the rat spinal cord: Studies with intrathecal 7-benzylidenenaltrexone, J. Pharmacol. Exp. Ther., 274, 1317, 10.1016/S0022-3565(25)10651-4 · DOI
  10. Hiller, 1987, Selective changes in mu, delta, and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients, Brain Res., 106, 17, 10.1016/0006-8993(87)90764-5 · DOI
  11. Itoh, 1990, Utility of an elevated plus-maze for the evaluation of memory in mice: Effects of nootropics, scopolamine and electroconvulsive shock, Psychopharmacology, 101, 27, 10.1007/BF02253713 · DOI
  12. Itoh, 1993, Dynorphin A-(1-13) markedly improves scopolamine-induced impairment of spontaneous alternation performance in mice, Eur. J. Pharmacol., 236, 341, 10.1016/0014-2999(93)90469-X · DOI
  13. Itoh, 1994, Dynorphin A-(1-13) potently improves the impairment of spontaneous alternation performance induced by the μ-selective opioid receptor agonist DAMGO in mice, J. Pharmacol. Exp. Ther., 269, 15, 10.1016/S0022-3565(25)38666-0 · DOI · Paper page
  14. Izquierdo, 1980, Effect of β-endorphin and naloxone on acquisition, memory, and retrieval of shuttle avoidance and habituation learning in rats, Psychopharmacology, 69, 111, 10.1007/BF00426531 · DOI
  15. Jiang, 1991, Differential antagonism of opioid delta-antinociception by [d-Ala2,Leu5,Cys6]enkephalin and naltrindole 5′-isothiocyanate: Evidence for delta-receptor subtypes, J. Pharmacol. Exp. Ther., 257, 1069, 10.1016/S0022-3565(25)24666-3 · DOI
  16. Kameyama, 1986, Step-down-type passive avoidance- and escape-learning method suitability for experimental amnesia models, J. Pharmacol. Methods, 16, 39, 10.1016/0160-5402(86)90027-6 · DOI
  17. Martin, 1984, Pharmacology of opioids, Pharmacol. Rev., 35, 283, 10.1016/S0031-6997(25)06637-2 · DOI
  18. Martinez, 1980, Endorphins after acquisition and consolidation of an inhibitory avoidance response in rats, Neurosci. Lett., 19, 197, 10.1016/0304-3940(80)90194-9 · DOI
  19. Mosberg, 1983, Bis-penicillamine enkephalins possess highly improved specificity towards delta opioid receptors, Proc. Natl. Acad. Sci. USA, 80, 5871, 10.1073/pnas.80.19.5871 · DOI
  20. Mulder, 1984, κ- and δ-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release, Nature, 308, 278, 10.1038/308278a0 · DOI
  21. Parada-Turska, 1990, Excitatory amino acid antagonists and memory: Effect of drugs acting at N-methyl-d-aspartate receptors in learning and memory tasks, Neuropharmacology, 29, 1111, 10.1016/0028-3908(90)90034-O · DOI
  22. Pasternak, 1993, Pharmacological mechanisms of opioid analgesics, Clin. Neuropharmacol., 16, 1, 10.1097/00002826-199302000-00001 · DOI
  23. Paterson, 1983, Classification of opioid receptors, Br. Med. Bull., 39, 25, 10.1093/oxfordjournals.bmb.a071787 · DOI
  24. Portoghese, 1992, A highly selective δ1-opioid receptor antagonist: 7-Benzylidenenaltrexone, Eur. J. Pharmacol., 218, 195, 10.1016/0014-2999(92)90167-3 · DOI
  25. Rady, 1994, Supraspinal delta receptor subtype activity of heroin and 6-monoacetylmorphine in Swiss Webster mice, Life Sci., 55, 603, 10.1016/0024-3205(94)00486-2 · DOI
  26. Sarter, 1988, Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and agonist β-carbolines, Psychopharmacology, 94, 491, 10.1007/BF00212843 · DOI
  27. Schulteis, 1988, Stimulation and antagonism of opioid δ-receptors produce opposite effects on active avoidance conditioning in mice, Behav. Neurosci., 102, 678, 10.1037/0735-7044.102.5.678 · DOI
  28. Sofuoglu, 1991, Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes, J. Pharmacol. Exp. Ther., 257, 676, 10.1016/S0022-3565(25)24699-7 · DOI
  29. Stahl, S.M., 1996. Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge University Press, Cambridge.
  30. Takemori, 1993, The mixed antinociceptive agonist-antagonist activity of β-endorphin (1–27) in mice, Life Sci., 53, 1049, 10.1016/0024-3205(93)90257-4 · DOI
  31. Tjon, 1995, Intermittent and chronic treatment induces long-lasting changes in δ-opioid receptor-regulated acetylcholine release in rat striatum and nucleus accumbens, Eur. J. Pharmacol., 283, 169, 10.1016/0014-2999(95)00319-G · DOI
  32. Ukai, 1993, Dynorphin A-(1–13) attenuates basal forebrain-lesion-induced amnesia in rats, Brain Res., 625, 355, 10.1016/0006-8993(93)91082-4 · DOI
  33. Ukai, 1995, Dynorphin A-(1–13) potently improves scopolamine-induced impairment of passive avoidance response in mice, Eur. J. Pharmacol., 274, 89, 10.1016/0014-2999(94)00710-O · DOI
  34. Ukai, 1995, κ-Opioid receptor agonists improve pirenzepine-induced disturbance of spontaneous alternation performance in the mouse, Eur. J. Pharmacol., 281, 173, 10.1016/0014-2999(95)00239-H · DOI
  35. Ukai, 1995, Attenuation of memory with Tyr-d-Arg–Phe-β-Ala–NH2, a novel dermorphin analog, with high affinity for μ-opioid receptors, Eur. J. Pharmacol., 287, 245, 10.1016/0014-2999(95)00492-0 · DOI
  36. Walker, 1991, Naloxone modulates the behavioral effects of cholinergic agonists and antagonists, Psychopharmacology, 105, 57, 10.1007/BF02316864 · DOI
  37. Wüster, 1981, Multiple opiate receptors in peripheral tissue preparations, Biochem. Pharmacol., 30, 1883, 10.1016/0006-2952(81)90194-5 · DOI

Cited by

Sorted by citations

Metadata

Authors
Ukai, M., Takada, A., Sasaki, Y., & Kameyama, T.
Affiliations
Meijo University (JP)
Corresponding author
Ukai, Makoto
Venue
European Journal of Pharmacology
Publisher
Elsevier BV
Published
1997-10
Volume
338
Issue
1
Pages
1-6
ISSN
0014-2999 (ISSN-L)
OpenAlex
W2084977336
Cited by
33
References
0
Citations by year
2023: 1 · 2020: 1 · 2019: 2 · 2016: 2 · 2015: 2 · 2013: 3
FWCI
0.52
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Ministry of Education, Culture, Sports, Science and Technology
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
opioid agonists, amnesia, passive avoidance learning, spontaneous alternation, elevated plus maze, deltorphin, 7-benzylidenenaltrexone, naltriben, nociception
MeSH terms
Amnesia, Analgesia, Animals, Avoidance Learning, Behavior, Animal, Electroshock, Enkephalins, Male, Oligopeptides, Receptors, Opioid, delta, Enkephalin, D-Penicillamine (2,5)-, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review